Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021

Lewis, James W.; Loughran, Julie; Deng, Li; Varghese, Jasmine; Clark, Shauna; Harrison, Casandra; Gacetta, Molly; Jernigan, John A.; Fleming-Dutra, Katherine E.

doi:10.3201/eid2811.221043

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021

11 2022
By Lewis, James W. ; Loughran, Julie ; Deng, Li ; ...
http://dx.doi.org/10.3201/eid2811.221043
Source: Emerg Infect Dis. 2022; 28(11):2338-2341

[PDF-333.13 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Lewis, James W. ; Loughran, Julie ; Deng, Li ; Varghese, Jasmine ; Clark, Shauna ; ... More +

Lewis, James W. ; Loughran, Julie ; Deng, Li ; Varghese, Jasmine ; Clark, Shauna ; Harrison, Casandra ; Gacetta, Molly ; Jernigan, John A. ; Fleming-Dutra, Katherine E. Less -
Description:

A SARS-CoV-2 P.1 (Gamma) variant outbreak occurred at a skilled nursing facility in Washington, USA, in April 2021. Effectiveness of 2 doses of mRNA vaccines against P.1 infection among residents in this outbreak was 75.0% (95% CI 44.5%-88.7%), similar to effectiveness for other pre-Delta variants among long-term care residents.
Subjects:

[+]

Coronavirus Disease COVID-19 Humans Long-Term Care P.1 Respiratory Infections SARS-COV-2 Severe Acute Respiratory Syndrome Coronavirus 2 United States Vaccine Effectiveness Vaccine Effectiveness Against SARS-COV-2 Variant P.1 In Nursing-Facility Residents, , Usa, April 2021 Vaccine Efficacy Viruses Washington Zoonoses
Source:

Emerg Infect Dis. 2022; 28(11):2338-2341
Pubmed ID:

36170764
Pubmed Central ID:

PMC9622236
Document Type:

Journal Article
Genre:

Letter
Place as Subject:

Washington
Volume:

28
Issue:

11
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:40e90b451423dca5d7bc9ecbfec224333fd61d5d7833f132d18e0236732d8101
Download URL:

https://stacks.cdc.gov/view/cdc/122132/cdc_122132_DS1.pdf
File Type:

	22-1043-F.gif	gif
	22-1043-F.jpg	jpeg
	22-1043-Techapp-s1.pdf	pdf
	22-1043.nxml	xml

More +